Skip to main content
Journal cover image

1257O Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib)

Publication ,  Conference
Hong, DS; Bang, Y-J; Barlesi, F; Durm, GA; Falchook, GS; Govindan, R; Dy, GK; Park, K; Strickler, JH; Burns, TF; Kim, J; Ang, A; Lipford, JR ...
Published in: Annals of Oncology
September 2020

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Annals of Oncology

DOI

ISSN

0923-7534

Publication Date

September 2020

Volume

31

Start / End Page

S812 / S812

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hong, D. S., Bang, Y.-J., Barlesi, F., Durm, G. A., Falchook, G. S., Govindan, R., … Li, B. T. (2020). 1257O Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib). In Annals of Oncology (Vol. 31, pp. S812–S812). Elsevier BV. https://doi.org/10.1016/j.annonc.2020.08.1571
Hong, D. S., Y. -. J. Bang, F. Barlesi, G. A. Durm, G. S. Falchook, R. Govindan, G. K. Dy, et al. “1257O Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib).” In Annals of Oncology, 31:S812–S812. Elsevier BV, 2020. https://doi.org/10.1016/j.annonc.2020.08.1571.
Hong DS, Bang Y-J, Barlesi F, Durm GA, Falchook GS, Govindan R, et al. 1257O Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib). In: Annals of Oncology. Elsevier BV; 2020. p. S812–S812.
Hong, D. S., et al. “1257O Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib).” Annals of Oncology, vol. 31, Elsevier BV, 2020, pp. S812–S812. Crossref, doi:10.1016/j.annonc.2020.08.1571.
Hong DS, Bang Y-J, Barlesi F, Durm GA, Falchook GS, Govindan R, Dy GK, Park K, Strickler JH, Burns TF, Kim J, Ang A, Lipford JR, Ngarmchamnanrith G, Anderson A, Li BT. 1257O Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib). Annals of Oncology. Elsevier BV; 2020. p. S812–S812.
Journal cover image

Published In

Annals of Oncology

DOI

ISSN

0923-7534

Publication Date

September 2020

Volume

31

Start / End Page

S812 / S812

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis